These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 8851451

  • 1. Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.
    Sanders SW.
    Clin Ther; 1996; 18(1):2-34; discussion 1. PubMed ID: 8851451
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH, Malfertheiner P, Yeomans ND, Hawkey CJ, Howden CW.
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [Abstract] [Full Text] [Related]

  • 4. Drugs for treatment of peptic ulcers.
    Dajani EZ, Trotman BW.
    J Assoc Acad Minor Phys; 1992 Jul; 3(3):78-88. PubMed ID: 1353999
    [Abstract] [Full Text] [Related]

  • 5. The rationale of acid suppression in the treatment of acid-related disease.
    Mohamed AH, Hunt RH.
    Aliment Pharmacol Ther; 1994 Jul; 8 Suppl 1():3-10. PubMed ID: 7910047
    [Abstract] [Full Text] [Related]

  • 6. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan 15; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract] [Full Text] [Related]

  • 7. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB.
    Eur J Gastroenterol Hepatol; 1996 Oct 15; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M.
    Aliment Pharmacol Ther; 2004 Nov 15; 20 Suppl 6():1-10. PubMed ID: 15496213
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan 15; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract] [Full Text] [Related]

  • 12. Peptic ulcer disease: an update.
    Berardi RR, Dunn-Kucharski VA.
    Am Pharm; 1993 Jun 15; NS33(6):26-34. PubMed ID: 8100116
    [Abstract] [Full Text] [Related]

  • 13. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease.
    Tomita T, Fukuda Y, Tamura K, Tanaka J, Hida N, Kosaka T, Hori K, Sakagami T, Satomi M, Shimoyama T.
    Aliment Pharmacol Ther; 2002 Apr 15; 16 Suppl 2():204-9. PubMed ID: 11966543
    [Abstract] [Full Text] [Related]

  • 14. Gastric acid-dependent diseases: a twentieth-century revolution.
    Sachs G, Shin JM, Munson K, Scott DR.
    Dig Dis Sci; 2014 Jul 15; 59(7):1358-69. PubMed ID: 24852882
    [No Abstract] [Full Text] [Related]

  • 15. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK.
    Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114
    [Abstract] [Full Text] [Related]

  • 16. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U, Chey WD, Scheiman JM, Fendrick AM.
    Aliment Pharmacol Ther; 2002 Aug 22; 16(8):1491-501. PubMed ID: 12182749
    [Abstract] [Full Text] [Related]

  • 17. Acid-related disorders in the elderly.
    Franceschi M, Di Mario F, Leandro G, Maggi S, Pilotto A.
    Best Pract Res Clin Gastroenterol; 2009 Aug 22; 23(6):839-48. PubMed ID: 19942162
    [Abstract] [Full Text] [Related]

  • 18. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Aug 22; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 19. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
    Soll AH.
    JAMA; 1996 Feb 28; 275(8):622-9. PubMed ID: 8594244
    [Abstract] [Full Text] [Related]

  • 20. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
    Inatomi N, Matsukawa J, Sakurai Y, Otake K.
    Pharmacol Ther; 2016 Dec 28; 168():12-22. PubMed ID: 27514776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.